Objective To determine if measures of adverse childhood experiences and DNA methylation relate to indices of obesity in youth.
The goal of the current investigation was to determine if measures of ACE and DNA methylation predict cross-sectional indices of obesity in youth. Obesity was selected as the health outcome to examine as it is the medical problem associated with childhood adversity most apt to manifest in youth, and there is strong meta-analytic support for the association between child maltreatment and obesity. 21 
Methods
Participants were derived from a cohort of 321 children recruited between 2013 and 2016 as part of an investigation examining risk and resilience in maltreated children. Data were analyzed in 2017. The 321 children were from 235 families with several siblings and half siblings (range: 0-4 per family) included in the cohort. In the year prior to study enrollment, 37% of the children had an out-of-home placement because of reports of abuse or neglect. Another 15% of the children had prior allegations of maltreatment, and 48% of the sample was never referred to protective services. The children were from diverse socioeconomic status (SES) backgrounds (Hollingshead SES mean 3.34, SD 1.3, range [1] [2] [3] [4] [5] , and as discussed further below, had experienced a broad range of childhood adversities.
The primary study was designed to assess predictors of mental health outcomes, with the assessment of obesity collected on a subset of the children as an add-on to the primary investigation. Child trauma, DNA methylation, and obesity measures were available on a total of 234 participants. The DNA data were analyzed in 2 batches; once at the end of the second year of recruitment, and once at the completion of the study. For analytic purposes, the cohort analyzed in the first batch was the discovery sample (n = 160), and the cohort analyzed in the second batch was the replication sample (n = 74). Table I depicts the demographic and clinical characteristics of the discovery and replication cohorts.
Assessments from parents were collected during home visits and the majority of the child data for this study were collected at a day camp devised specifically for our research purposes, replicating a methodology used in previous investigations. [22] [23] [24] The institutional review boards at Yale University, University of Vermont, and Johns Hopkins Schools of Medicine approved this study. Prior to recruitment, an independent child advocate reviewed each case referred through protective services to determine that research participation was in the child's best interest. The child's parent or legal guardian provided informed consent and each child provided assent for study participation. Birth parent assent for child participation for children in state custody was obtained when clinically appropriate (eg, ongoing parent-child contact).
Multiple informants and data sources (eg, parents, children, protective services records) were used to obtain a best estimate of each child's adverse experiences. Permissions were secured to access state child protective services records from all study participants, and records were obtained for all children with prior protective services referrals (n = 122; 87 children recruited through protective services because of recent out-of-home placements and 35 children recruited through the community who were living with their biological families but had a history of prior protective services involvement). The data from these various sources were integrated and rated using the Yale-Vermont Adversity in Childhood Scale (Y-VACS) scoring procedures. 25 The Y-VACS assesses a range of intrafamilial (eg, physical abuse, witnessing domestic violence) and extrafamilial (eg, community violence, bullying, natural disasters) adversities, and generates scores that take into account severity and frequency of exposure. The Y-VACS generates a total adversity score, intrafamilial adversity score, extrafamilial adversity score, and individual item scores, with high inter-rater reliability reported in generating these scores. 25 As the children with and without prior protective services involvement did not differ on the extrafamial adversity scale of the Y-VACS (Wald c 2 = .237, df = 1, ns), children's scores on the intrafamilial adversity scale of the Y-VACS were used in subsequent analyses examining obesity risk.
The nurse at the research summer day camp program collected the measurements of height and weight which were used to calculate body mass index (BMI). The same scale was used for all children participating in the study.
Saliva specimens for DNA extraction were refrigerated within 2 hours of collection and DNA extracted using Puregene (Gentra, Minneapolis, Minnesota) kits. To prepare the specimens for the methylation study, 500 ng of genomic DNA were treated with bisulfite reagents included in the EZ-96 DNA methylation kit (Zymo Research, Orange, California) according to the manufacturer's protocol. Bisulfite-converted DNA samples were then used in the array-based DNA methylation assays.
The Illumina 450K Methylation BeadChip was used to analyze the DNA data of the discovery cohort (Illumina Inc, San Diego, California). Array-based epigenome-wide methylation analyses were completed at the Yale Center for Genome Analysis at Yale University using standard procedures. Quality control was conducted based on published methods. 26 Meth- Volume 202 • November 2018 ylation sites with detection P value of >.001 were removed to ensure that only high-confidence probes were included. Probes were also excluded if they had a single nucleotide polymorphism (SNP) within the methylation site map to multiple places in the genome or to sex chromosomes. Methylation data were normalized using the functional normalization method in the "minfi" R package. This function uses internal control probes present on the array to control for between-array technical variation and outperforms other approaches. 27 A total of 456 513, (94% of sites) were left for subsequent analysis. The genomic inflation factor for the discovery cohort was 1.004, indicating that the epigenome wide analyses results are negligibly inflated and the results are unlikely due to spurious findings (Figure 1 ; available at www.jpeds.com). The script and methods used to generate the genomic inflation factor parallel the methods utilized by Gelernter et al. 28 The Illumina Infinium Methylation EPIC (850K) BeadChip (Illumina, Inc) was used to assess DNA methylation in the replication cohort. Only the methylation sites that significantly predicted BMI in the children in the discovery cohort after controlling for whole genome testing (P < 5.0 × 10 −7 ) were examined in the replication cohort. The 850K BeadChip was likewise processed at the Yale Center for Genome Analysis.
Because methylation values at methylation sites can be celltype specific, 29 we conducted a cell composition estimation analysis using a modified version of the method by Housemann et al, 30, 31 and estimated the relative proportion of each cell type (eg, CD34, CD14, and buccal cells) in the heterogenous peripheral saliva samples.
DNA methylation can vary by race or ethnicity. 32, 33 To adjust for possible population stratification within the predominantly European American sample, we used a methylation-based principal component (PC) approach, 34 based on sets of methylation sites within 50 kb of SNPs using the 1000 Genomes Project variants with minor allele frequency of >0.1 following the Barfield et al method. 34 This method outperforms other methods that adjust for population stratification in methylation. 34 
Statistical Analyses
To control for familial correlations due to the inclusion of siblings in the cohort, generalized estimating equations (GEE) were used to examine the impact of intrafamilial adversity on BMI. Age, sex, and race were used as covariates in the GEE analysis (n = 234), and a separate GEE analysis was conducted with SES also included in the model for the subset of subjects with SES data (n = 175). In analyzing the methylation data for the discovery sample (https://cran.r-project.org/web/packages/lme4/ index.html), linear mixed-effects models were used to examine the main effect of methylation M-values and intrafamilial childhood adversity scores and the interaction of these 2 variables using the "lme4" function in R software environment (R Foundation for Statistical Computing, Vienna, Austria). Familial correlations were modeled by assigning a random effect to each family. Potential confounding factors including age, sex, race, cell type (eg, CD14, CD34, buccal), and the first 3 PCs were also included in the model. To correct for multiple comparison testing, significant threshold for analyses was set to
, consistent with prior recommendations. 35 Only the methylation sites that significantly predicted BMI in the children in the discovery cohort after controlling for whole genome testing (P < 5.0 × 10
) were examined in the replication cohort, with GEE used in these analyses with the same set of covariates listed above included in the models. The discovery cohort and replication samples were not analyzed together, as at present, methods do not exist to combine 450 K and 850 K data controlling for batch and BeadChip effects.
Results
The children in the cohort experienced a mean of 2.3 (SD = 2.3) intrafamilial adversities (range: 0-8), with 29% of the cohort reported to have experienced 4 or more intrafamilial adversities. Table II (available at www.jpeds.com) provides detailed information about the proportion of children to have experienced each ACE. Among the children in the maltreated cohort, 66% experienced physical abuse, 34% sexual abuse, 57% neglect, and 54% witnessed domestic violence. The Y-VACS scores of the discovery and replication cohorts are included in Table I . The higher intrafamilial adversity scores in the discovery cohort is likely attributable to the majority (82%) of the maltreated children with a recent out-of-home placement being recruited during the first 2 years of the study and included in the discovery cohort.
After controlling for age, sex, and race, the Y-VACS intrafamilial childhood adversity measure was a significant predictor of BMI (n = 234; P < .0001). Increased age (P < .0001) and African American ancestry (P < .04) also predicted greater BMI, but after accounting for the other measures in the model, sex (P < .11) was not a significant predictor of BMI. The Y-VACS intrafamilial childhood adversity score was still a significant predictor of BMI (P < .004) when SES was also included in the model, although these analyses were conducted on a smaller subset of subjects as SES data were missing for 25% of the sample, with missing SES data greatest for the most traumatized children-youth in out-of-home care who did not currently have any contact with their biological parents. Children who had high Y-VACS scores (n = 49), defined as 1 SD above the mean, were 16 times more likely to be obese than children who had low Y-VACS scores (n = 49), defined as 1 SD below the mean (percent obese: high Y-VACS: 16.3%; low Y-VACS: 1%, c 2 = 17.6, df = 3, P < .001). After controlling for age, sex, race, cell heterogeneity, the first 3 PCs, and whole-genome testing, 6 methylation sites were found to exert a main effect in predicting BMI, and an additional 10 methylation sites were found to interact with the adverse childhood experiences measure to predict BMI ( Table III) . The direction of the interaction effects varied by site, with some methylation sites being stronger predictors of BMI in youth with low intrafamilial adversity scores (eg, HID1, GALE), and other methylation sites being stronger predictors of BMI in youth with high intrafamilial adversity scores (eg, PRDM16, PXDN) . Eight of the 16 methylation sites identified in these analyses are in genes previously associated with obesity risk, and 3 were in intergenic regions.
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Metacore software was used to identify biological processes associated with the top epigenome wide significant hits. This package accounts for the varying number of methylation sites per gene by assigning a prior probability for each gene based on gene length, followed by a modified hypergeometric test for over-representation of a gene set. 36 Methylation sites that had significance values of P < 1.0 × 10 −5 were used in this analysis. To correct for multiple comparison testing, false discovery rate (FDR) was set at .05. Enrichment was seen in multiple muscle development and muscle cell proliferation processes, processes involved in responses to several different nutrients and glucocorticoids, as well as multiple processes relevant to translation and transcription. The top 50 significant gene ontology (GO) processes are included online only in Table IV (available at www.jpeds.com).
Of the 16 sites associated with obesity risk in the discovery cohort, 2 failed to pass quality control tests for analyses in the replication cohort; KCNS3 (cg0155585) and BCAT1 (cg15990629). As depicted in Table V, after controlling for age, sex, race, cell heterogeneity, and the first 3 PCs, the adversity measure and 4 of the methylation sites predicted BMI at nominal levels of significance, and the significance value associated with methylation in PCK2 withstood Bonferroni correction for multiple comparisons (P < .0031). The interaction term of trauma with the methylation value at the methylation site in GALE also approached statistical significance in the replication sample.
There are multiple methylation sites contained on the 450K BeadChip for each of the genes identified as significant predictors of obesity. As depicted online in Table VI (available at www.jpeds.com), nominal levels of significance in predicting BMI were attained at 8 additional sites in these genes.
Given the replicated finding with PCK2 across the 2 cohorts, follow-up mediation analyses were conducted using regression analyses and maintaining the demographic, cell heterogeneity, and PC covariates in the model. As depicted in Figure 2 , after controlling for the relevant covariates, support for a mediation model was attained, with the effects of intrafamilial childhood adversities on indices of obesity found to be mediated by epigenetic changes in the PCK2, a gene implicated in obesity risk in a prior epigenome wide association study. 37 
Discussion
In the current investigation, ACEs predicted cross-sectional assessments of BMI in the children. Children who had high intrafamilial adversity scores, defined as 1 SD above the mean, were 16 times more likely to be obese than children who had low intrafamilial adversity scores, defined as 1 SD below the mean. The findings of this investigation are consistent with the results of a recent meta-analysis of 41 studies examining the association of child maltreatment and obesity. 21 The authors of that meta-analysis concluded that child maltreatment is a potentially modifiable risk factor for obesity, and future The covariates age, sex, race, cell type (CD14, CD34, buccal), and the first 3 PCs to account for population stratification were included in all analyses. The direction of the associations between BMI and the methylation markers was the same in the discovery and replication cohorts at each methylation site, except cg26103104.
research should clarify the mechanisms through which child maltreatment affects obesity risk. The present study suggests child maltreatment may confer risk for obesity through epigenetic mechanisms. Among the subjects in the discovery data set, after controlling for age, sex, race, cell heterogeneity, 3 PCs, and whole-genome testing, 10 methylation sites were found to interact with the ACE measure to predict cross-sectional assessments of BMI, and an additional 6 sites were also found to exert a main effect in predicting BMI.
Eight of the methylation sites identified in the discovery data set are in genes previously associated with obesity risk or functionally related to relevant biological indices. Specifically, PCK2 encodes an enzyme in mitochondria involved in glucose metabolism. It is mainly expressed in liver, pancreas, intestine fibroblasts and is involved in the insulin signaling pathway, with genetic variation in PCK2 previously found to predict individual differences in response to dietary interventions.
38 CXCL10 encodes a chemokine, with values of CXCL10 found to correlate significantly with measures of visceral fat area in obese children. 39 The protein product of BCAT1 catalyzes the first reaction in the catabolism of the essential branched chain amino acids leucine, isoleucine, and valine and has been identified as a candidate risk gene for obesity. 40 HIDI is associated with body fat mass regulation, preadipocyte number and adipocyte size in rats. 41 The PRDM16 protein product is involved in the differentiation of brown adipose tissue, and the PRDM16 transcriptional pathway has been identified as promising for the development of novel therapeutic interventions for the treatment of obesity and obesity-related diseases. 42 OSBPL9 encodes a member of the oxysterol-binding protein family, a group of intracellular lipid receptors. 43 MADD variants are implicated in type 2 diabetes and have been associated with fasting proinsulin levels in genome wide association studies. 44 PXDN deletions have been associated with early onset obesity, 45, 46 and GALE encodes UDP-galactose-4-epimerase which catalyzes 2 distinct but analogous reactions with important metabolic consequences. 47 Although the exact methylation sites identified in the current investigation have not been reported in prior epigenome-wide studies of obesity risk, 37, [48] [49] [50] [51] [52] [53] methylation of other methylation sites in 4 of the genes identified in this study (eg, PCK2, MADD, PRDM16, BCAT1) were reported in the prior investigations. 37, [48] [49] [50] 53 Three of the significant methylation sites identified in the discovery data set were in intergenic regions. Many methylation islands in intergenic regions are enriched for factor binding sites and are involved in the 3-dimensional organization of the genome and gene regulation. 54, 55 Transcription factor binding sites and chromatin insulators within intergenic regions are believed to mediate intra-and interchromosomal interactions, affecting gene expression at both proximal and distal locations, 55 and there are numerous instances where intergenic genetic variation is associated with disease risk. 56 Results of the gene ontology analysis conducted in the discovery cohort with the top epigenome wide significant hits (P < 1.0 × 10-5) found enrichment in multiple biologically relevant processes. Muscle development and muscle cell proliferation processes were enriched among the methylation sites with the highest association with BMI. Processes involved in responses to several different nutrients (eg, vitamin A, vitamin D, iron) and glucocorticoids, as well as multiple processes relevant to translation and transcription were also enriched in the top epigenome significant findings.
In terms of the replication analyses, even though the replication sample was small (n = 74) and had a lower prevalence of obesity and history of childhood adversities, several of the findings from the discovery data set were also significant predictors of BMI in the second cohort. The most robust of the findings involved PCK2, with this result withstanding Bonferroni correction for multiple comparisons. In addition, follow-up analyses with PCK2 provided support for a mediation model in which the effects of intrafamilial childhood adversities on indices of obesity were found to be mediated by epigenetic changes in PCK2.
Although prior literature indicates that DNA methylation levels in saliva are similar to those in peripheral blood, skin Indirect effects of intrafamilial childhood adversities on BMI through methylation of PCK2. After controlling for the relevant demographic factors (eg, age, sex, race), cell heterogeneity measures (eg, CD34, CD14, and buccal cells), and the first 3 PCs, support for a mediation model was attained, with the effects of intrafamilial childhood adversities on indices of obesity found to be mediated by epigenetic changes in the PCK2, a gene implicated in obesity risk in a prior epigenome wide study. ** = P < .01; *** = P < .0001.
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Volume 202 fibroblasts, and buccal swab DNA, it may not reflect the epigenome of adipose tissue, muscle, pancreas, gastrointestinal system, or the pituitary-tissues most relevant in obesity. 57, 58 Additional limitations of the current investigation include small size of the replication cohort, use of the 450K BeadChip, which does not include methylation sites at the most replicated previously identified obesity genetic risk SNPs, limiting the test of these genes in the current investigation, use of the 850K platform in the replication cohort, the lack of genetic variant and gene expression data, the absence of food intake and exercise data, 59 failure to assess prenatal factors known to affect methylation and obesity risk, [60] [61] [62] and the cross-sectional nature of the study which limits inferences that can be made regarding the causal consequences of the methylation findings.
The data reported in this article suggest adverse childhood experiences may confer risk for health problems through epigenetic mechanisms. Although epigenetic modifications are frequently long lasting, they can sometimes be reversed. This study lays the groundwork for future longitudinal clinical and translational studies to further elucidate these mechanisms and identify novel prevention and treatment interventions to alleviate the health burden associated with early adversity. ■ Figure 1 . Quantile-quantile (Q-Q) plots. The figure above depicts the Q-Q plots for the P values of the association. The genomic inflation factor for the discovery cohort was 1.004, indicating that the epigenome wide analyses results are negligibly inflated and the results are unlikely due to spurious findings. As noted in the manuscript, the majority (71/87, 82%) of the maltreated children who were recruited after a recent out-of-home placement were recruited during the first 2 years of the study, accounting for the greater rate of adversity in the discovery cohort. 
